Skip to content

Welcoming our 2024-2026 Cohort of HEOR Fellows

The CHOICE Institute is pleased to announce the 2024-26 cohort of HEOR Fellows who will start their programs on July 1, 2024. Our HEOR fellows work closely with faculty in the CHOICE Institute on projects where they learn first-hand how to apply the principles of outcomes research to real-life problems. These fellowships provide students with a year of study at the University of Washington, usually combined with a period of applied research at the sponsoring company. The year of study leads to an MS degree in Health Economics & Outcomes Research.

These training programs in health economics, outcomes research, and policy each combine the resources of a leading academic center for pharmaceutical economics and policy with the dynamic, real-world training of major pharmaceutical and biotechnology companies recognized for their commitment to innovation. Read more about our industry fellowship programs.

This year, we are excited to be welcoming our largest cohort of fellows to date– with the launch of our two new industry partnerships, with Novo Nordisk and Sanofi.

Meet the fellows:


Rachel Kneitel, St. John’s University

Olivia Yip, University of California San Diego


Jean Lee, University of Illinois at Chicago


Nissen Weisman, University of Connecticut 

Divya Jain, University of Colorado Denver 

Novo Nordisk

Minseon Chung, University at Buffalo 


Kevin Li, University of Washington 


Kathryn Perkins, University of Southern California